Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 74
Filter
1.
Int J Offender Ther Comp Criminol ; 63(15-16): 2586-2610, 2019.
Article in English | MEDLINE | ID: mdl-31387425

ABSTRACT

Cognitive and behavioral treatment programs for individuals who have committed sexual offenses (ISOs) have shown significant but small effect sizes. A growing body of research points toward the importance of difficulties in affect regulation (AR) as a risk factor for sexual recidivism. On this basis, it seems important to target difficulties in AR in treatment. The current systematic case study investigates the potential contribution of emotion-focused therapy (EFT) to changing problematic AR in ISOs. Kevin was a high-risk offender with a traumatic history who met the diagnostic criteria of pedophilic and borderline disorders, with serious AR difficulties. Self-report outcome measures, observation measures, and a biomarker were used to track changes in AR, psychological symptoms, and distress during baseline (Phase A); treatment as usual (Phase B); treatment with an EFT component added (Phase C); and follow-up (Phase A). Statistically significant change was found in AR, psychological symptoms, and distress during treatment (Phase B + C); however, it is not possible to attribute these changes causally to EFT. An examination of the qualitative process data provides deeper insights into how the client reacted to specific EFT interventions. Verbatim clinical vignettes are included to clarify key interventions, hindrances, and mechanisms of change. This study provides preliminary support for the role of therapy to facilitate emotional change in ISOs.


Subject(s)
Borderline Personality Disorder/psychology , Cognitive Behavioral Therapy , Emotional Regulation , Pedophilia/psychology , Recidivism/prevention & control , Sex Offenses/psychology , Adult , Follow-Up Studies , Humans , Male , Outcome Assessment, Health Care , Psychological Distress , Psychotherapy, Group , Risk Factors , Single-Case Studies as Topic
2.
Clin Pharmacol Ther ; 90(3): 377-87, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21814197

ABSTRACT

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting side effect of many chemotherapeutic agents. Although many therapies have been investigated for the prevention and/or treatment of CIPN, there is no well-accepted proven therapy. In addition, there is no universally accepted, well-validated measure for the assessment of CIPN. The agents for which there are the strongest preliminary data regarding their potential efficacy in preventing CIPN are intravenous calcium and magnesium (Ca/Mg) infusions and glutathione. Agents with the strongest supporting evidence for efficacy in the treatment of CIPN include topical pain relievers, such as baclofen/amitriptyline/ketamine gel, and serotonin and norepinephrine reuptake inhibitors, such as venlafaxine and duloxetine. Other promising therapies are also reviewed in this paper. Cutaneous electrostimulation is a nonpharmacological therapy that appears, from an early pilot trial, to be potentially effective in the treatment of CIPN. Finally, there is a lack of evidence of effective treatments for the paclitaxel acute pain syndrome (P-APS), which appears to be caused by neurologic injury.


Subject(s)
Antineoplastic Agents/adverse effects , Pain/chemically induced , Pain/drug therapy , Peripheral Nervous System Diseases/chemically induced , Antineoplastic Agents/therapeutic use , Humans , Pain/prevention & control , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/prevention & control , Treatment Outcome
3.
Environ Entomol ; 40(3): 621-32, 2011 Jun.
Article in English | MEDLINE | ID: mdl-22251640

ABSTRACT

Wild bees provide vital pollination services for many native and agricultural plant species, yet the landscape conditions needed to support wild bee populations are not well understood or appreciated. We assessed the influence of landscape composition on bee abundance and species richness in apple (Malus spp.) orchards of northeastern Wisconsin during the spring flowering period. A diverse community of bee species occurs in these apple orchards, dominated by wild bees in the families Andrenidae and Halictidae and the honey bee, Apis mellifera L. Proportion of forest area in the surrounding landscape was a significant positive predictor of wild bee abundance in orchards, with strongest effects at a GIS (Geographic Information Systems) buffer distance of 1,000 m or greater. Forest area also was positively associated with species richness, showing strongest effects at a buffer distance of 2,000 m. Nonagricultural developed land (homes, lawns, etcetera) was significantly negatively associated with species richness at buffer distances >750 m and wild bee abundance in bowl traps at all distances. Other landscape variables statistically associated with species richness or abundance of wild bees included proportion area of pasture (positive) and proportion area of roads (negative). Forest area was not associated with honey bee abundance at any buffer distance. These results provide clear evidence that the landscape surrounding apple orchards, especially the proportion of forest area, affects richness and abundance of wild bees during the spring flowering period and should be a part of sustainable land management strategies in agro-ecosystems of northeastern Wisconsin and other apple growing regions.


Subject(s)
Bees , Biodiversity , Agriculture , Animals , Geography , Malus , Wisconsin
4.
J Hum Evol ; 54(5): 675-83, 2008 May.
Article in English | MEDLINE | ID: mdl-18023469

ABSTRACT

The evolution of habitual bipedalism is still a fundamental yet unsolved question for paleoanthropologists, and carrying is popular as an explanation for both the early adoption of upright walking and as a positive selection pressure once a terrestrial lifestyle had been adopted. However, to support or reject any hypothesis that suggests carrying efficiency was an important selective pressure, we need quantitative data on the costs of different forms of carrying behavior, especially infant-carrying since reduction in the grasping capabilities of the foot would have prevented infants from clinging on for long durations. In this study, we tested the hypothesis that the mode of load carriage influences the energetic cost of locomotion. Oxygen consumption was measured in seven female participants walking at a constant speed while carrying four different 10-kg loads (a weighted vest, 5-kg dumbbells carried in each hand, a mannequin infant carried on one hip, and a 10-kg dumbbell carried in a single hand). Oxygen consumption was also measured during unloaded standing and unloaded walking. The results show that the weighted vest requires the least amount of energy of the four types of carrying and that, for this condition, humans are as efficient as mammals in general. The balanced load was carried with approximately the predicted energy cost. However, the asymmetrical conditions were considerably less efficient, indicating that, unless infant-carrying was the adaptive response to a strong environmental selection pressure, this behavior is unlikely to have been the precursor to the evolution of bipedalism.


Subject(s)
Anthropology, Physical , Lifting , Oxygen Consumption/physiology , Walking/physiology , Weight-Bearing/physiology , Adult , Biological Evolution , Exercise Test , Female , Humans , Random Allocation
5.
J Anat ; 210(1): 32-40, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17229281

ABSTRACT

Three muscles from the proximal equine forelimb were dissected in order to investigate their potential to contribute to proximal limb mechanics. Muscle mass, fibre length, tendon mass and tendon length were measured from biceps brachii, triceps brachii, supraspinatus and lacertus fibrosus (biceps lateral head mass 171-343.4 g and fibre length 0.5-0.8 cm; biceps medial head mass 283-500 g and fibre length 2.2-4 cm; biceps tendon mass 121.8-260 g and tendon length 35-44 cm; triceps long head mass 3200-6663 g and fibre length 19-26.3 cm; triceps lateral head mass 513.8-1240 g and fibre length 17.5-24 cm; triceps medial head mass 85.2-270.6 g and fibre length 9-16.8 cm; supraspinatus mass 793-1546 g and fibre length 4.7-12.4 cm; lacertus fibrosus mass 4.6-12.4 g and length 10-16 cm). Physiological cross-sectional area (PCSA) and maximum isometric force were estimated for each muscle, and moment arm measurements were taken at the shoulder and elbow joints. Biceps has a greater isometric force-generating capacity than supraspinatus. It also appears to have a larger shoulder moment arm, so could therefore have the potential to make a greater contribution to the shoulder moment than supraspinatus. Supraspinatus is likely to function primarily as a shoulder stabilizer rather than a shoulder extensor. Biceps also functions as an elbow flexor and data here indicate that it has a greater PCSA and isometric force-generating capacity than its antagonist triceps brachii. Calculation of tendon forces showed that the biceps tendon can withstand much greater forces than lacertus fibrosus. This study will enable further investigation into the interaction between energy recycling in elastic tissues and the generation and absorption of mechanical work by adjacent muscle groups in the equine forelimb.


Subject(s)
Horses/anatomy & histology , Muscle, Skeletal/anatomy & histology , Animals , Biomechanical Phenomena , Forelimb , Hindlimb , Muscle Fibers, Skeletal/ultrastructure , Tendons/anatomy & histology
6.
J Exp Clin Cancer Res ; 24(2): 279-87, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16110762

ABSTRACT

The purpose of the following study is to describe the localization of COX-2 protein and COX-2 mRNA during human colorectal tumorigenesis and to identify potential cellular targets for COX-2 inhibition in chemopreventive strategies. Immunohistochemistry with digital image analysis was used to determine COX-2 protein expression in histologic sections containing synchronous normal colorectal mucosa, adenomas and carcinomas, from 17 previously untreated patients. Epithelial and stromal COX-2 mRNA expression was analyzed by reverse transcription-polymerase chain reaction (RT-PCR), on laser-capture microdissected samples from the same histologies. The stromal compartment in normal colorectal mucosa and adenomas showed higher levels of COX-2 protein expression compared to colorectal carcinomas (p < .0001). Conversely, epithelial COX-2 protein was significantly increased only after development of the invasive phenotype (p < .0001). RT-PCR demonstrated higher stromal COX-2 mRNA expression compared to that within the epithelium for colorectal adenomas and carcinomas. In conclusion, stromal COX-2 may be the target for chemopreventive agents in the early stages of colorectal carcinogenesis.


Subject(s)
Colorectal Neoplasms/enzymology , Epithelial Cells/enzymology , Stromal Cells/enzymology , Adenoma/metabolism , Blotting, Southern , Blotting, Western , Carcinoma/metabolism , Cell Line, Tumor , Cell Proliferation , Cell Transformation, Neoplastic , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/metabolism , DNA, Complementary/metabolism , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Phenotype , Polymerase Chain Reaction , RNA/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Time Factors
7.
Biomed Sci Instrum ; 41: 394-9, 2005.
Article in English | MEDLINE | ID: mdl-15850138

ABSTRACT

One of the leading causes of implantable device failure is build up of scar tissue on the device. Approaches to address this complication range from choosing device materials that prevent cell adhesion to treatment with potent antifibrotic medications such as mitomycin C. We examined the collagen matrix around aqueous shunt implants in rabbit eyes and found the filtration capsule formed around these devices is not composed of scar tissue. Rather collagen deposition is highly organized with collagen bundles oriented along stress axes. We also examined adjacent tissue deposition in mitomycin C treated animals and found decreased vascularization, condensed collagen in Tenon's capsule with more collagen bundles less well formed than those in the control eye of the same animal. The sclera was thicker under the plate than at the opposite side of the same eye. Structural and functional evaluation correlates with the clinical paradox that patients treated with mitomycin C have lower initial pressures with adjunct drug treatment but lower success rates than the control population after 18 months.


Subject(s)
Glaucoma Drainage Implants/adverse effects , Glaucoma/pathology , Glaucoma/surgery , Mitomycin/administration & dosage , Prosthesis-Related Infections/pathology , Prosthesis-Related Infections/prevention & control , Animals , Antibiotics, Antineoplastic/administration & dosage , Chemotherapy, Adjuvant , Fibrosis , Glaucoma/drug therapy , Prosthesis-Related Infections/etiology , Rabbits , Sclera/drug effects , Sclera/pathology , Sclera/surgery , Treatment Outcome
8.
Mutat Res ; 501(1-2): 137-41, 2002 Apr 25.
Article in English | MEDLINE | ID: mdl-11934445

ABSTRACT

A polymorphic Alu element belonging to the young Ya5 subfamily of Alu repeats located in the progesterone receptor gene has been characterized. Using a polymerase chain reaction (PCR)-based assay, the genetic diversity associated with the PROGINS Alu repeat was determined in a diverse array of human populations. The level of insertion polymorphism associated with PROGINS suggests that it will be a useful marker for the study of human evolution. In addition, we determined the distribution of the PROGINS Alu insertion in two groups of women from greater New Orleans, LA with breast cancer. The PROGINS Alu insertion was not associated with breast cancer in the populations tested.


Subject(s)
Alu Elements/genetics , Genetic Variation , Genome, Human , Receptors, Progesterone/genetics , Animals , Breast Neoplasms/etiology , Breast Neoplasms/genetics , Female , Humans , Louisiana , Phylogeny
9.
Br J Cancer ; 85(2): 266-72, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11461088

ABSTRACT

We hypothesized that non-proliferating (quiescent) human vascular endothelial cells would not express somatostatin receptor subtype 2 (sst 2) and that this receptor would be expressed when the endothelial cells begin to grow. To test this hypothesis, placental veins were harvested from 6 human placentas and 2 mm vein disks were cultured in 0.3% fibrin gels. Morphometric analysis confirmed that 50-75% of cultured vein disks developed radial capillary growth within 15 days. Sst 2 gene expression was determined by reverse transcription-polymerase chain reaction (RT-PCR) analysis of the RNA from veins before culture and from tissue-matched vein disks that exhibited an angiogenic response. The sst 2 gene was expressed in the proliferating angiogenic sprouts of human vascular endothelium. The presence of sst 2 receptors on proliferating angiogenic vessels was confirmed by immunohistochemical staining and in vivo scintigraphy. These results suggest that sst 2 may be a unique target for antiangiogenic therapy with sst 2 preferring somatostatin analogues conjugated to radioisotopes or cytotoxic agents.


Subject(s)
Endothelium, Vascular/metabolism , Receptors, Somatostatin/metabolism , Animals , Base Sequence , Cells, Cultured , Culture Techniques , DNA Primers , Endothelium, Vascular/cytology , Gene Expression , Humans , Immunohistochemistry , Mice , Mice, Nude , Neovascularization, Physiologic , Receptors, Somatostatin/genetics , Reverse Transcriptase Polymerase Chain Reaction
11.
Neurosurgery ; 48(4): 884-92; discussion 892-3, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11322449

ABSTRACT

OBJECTIVE: Deleterious effects of strokes may be ameliorated when thrombolysis (i.e., with recombinant tissue plasminogen activator) restores circulation. However, reperfusion injury, mediated by oxygen free radicals (reactive oxygen species [ROS]), may limit the benefits of recombinant tissue plasminogen activator treatment. We hypothesized that, during reperfusion, exogenous nitric oxide (NO) would reduce stroke size by quenching ROS. METHODS: To investigate this hypothesis, we used two in vivo ischemia-reperfusion models, i.e., autologous cerebral embolism in rabbits and filament middle cerebral artery occlusion in rats. Using these models, we measured ROS levels (rabbit model) and stroke volumes (rat model) in response to transient ischemia, with and without intracarotid administration of ultrafast NO donor proline NO (proliNO). RESULTS: In the rabbit cerebral embolism model, intracarotid administration of proliNO (10(-6) mol/L) (n = 6) during reperfusion decreased free radical levels from 538 +/- 86 nmol/L in the vehicle-treated group (n = 7) to 186 +/- 31 nmol/L (2,3'-dihydroxybenzoic acid; P < 0.001) and from 521 +/- 86 nmol/L (n = 7) to 201 +/- 39 nmol/L (2,5'-dihydroxybenzoic acid; P < 0.002). In the rat middle cerebral artery occlusion model, intracarotid administration of proliNO (10(-5) mol/L) (n = 10) during reperfusion reduced the brain infarction volume from 256 +/- 48 mm3 in the vehicle-treated group (n = 8) to 187 +/- 41 mm3 (P < 0.005). In both experimental groups, intracarotid infusion of proliNO did not affect regional cerebral blood flow, mean arterial blood pressure, or brain and body temperatures. CONCLUSION: The beneficial effects of early restoration of cerebral circulation after cerebral ischemia were enhanced by intracarotid infusion of proliNO, most likely because of ROS scavenging by NO. These findings suggest the possibility of preventive treatment of reperfusion injury using NO donors.


Subject(s)
Infarction, Middle Cerebral Artery/physiopathology , Intracranial Embolism/physiopathology , Nitric Oxide Donors/pharmacology , Nitric Oxide/pharmacology , Proline/pharmacology , Reactive Oxygen Species/metabolism , Reperfusion Injury/physiopathology , Animals , Brain/blood supply , Female , Infarction, Middle Cerebral Artery/pathology , Injections, Intra-Arterial , Intracranial Embolism/pathology , Male , Nitrogen Oxides , Proline/analogs & derivatives , Rabbits , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Reperfusion Injury/pathology
13.
J Neurosurg ; 92(6): 1028-35, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10839266

ABSTRACT

Generally accepted contraindications to using a transsphenoidal approach for resection of tumors that arise in or extend into the suprasellar region include a normal-sized sella turcica, normal pituitary function, and adherence of tumor to vital intracranial structures. Thus, the transsphenoidal approach has traditionally been restricted to the removal of tumors involving the pituitary fossa and, occasionally, to suprasellar extensions of such tumors if the sella is enlarged. However, conventional transcranial approaches to the suprasellar region require significant brain retraction and offer limited visualization of contralateral tumor extension and the interface between the tumor and adjacent structures, such as the hypothalamus, third ventricle, optic apparatus, and major arteries. In this paper the authors describe successful removal of suprasellar tumors by using a modified transsphenoidal approach that circumvents some of the traditional contraindications to transsphenoidal surgery, while avoiding some of the disadvantages of transcranial surgery. Four patients harbored tumors (two craniopharyngiomas and two hemangioblastomas) that arose in the suprasellar region and were located either entirely (three patients) or primarily (one patient) within the suprasellar space. All patients had a normal-sized sella turcica. Preoperatively, three of the four patients had significant endocrinological deficits signifying involvement of the hypothalamus, pituitary stalk, or pituitary gland. Two patients exhibited preoperative visual field defects. For tumor excision, a recently described modification of the traditional transsphenoidal approach was used. Using this modification, one removes the posterior portion of the planum sphenoidale, allowing access to the suprasellar region. Total resection of tumor was achieved (including absence of residual tumor on follow-up imaging) in three of the four patients. In the remaining patient, total removal was not possible because of adherence of tumor to the hypothalamus and midbrain. One postoperative cerebrospinal fluid leak occurred. Postoperative endocrinological function was worse than preoperative function in one patient. No other new postoperative endocrinological or neurological deficits were encountered. This study demonstrates the feasibility of using a modified transsphenoidal approach for resection of certain suprasellar, nonpituitary tumors.


Subject(s)
Craniopharyngioma/surgery , Hemangioblastoma/surgery , Sella Turcica , Skull Neoplasms/surgery , Adolescent , Adult , Child , Craniopharyngioma/diagnosis , Craniopharyngioma/pathology , Female , Hemangioblastoma/diagnosis , Hemangioblastoma/etiology , Hemangioblastoma/pathology , Humans , Intraoperative Period , Magnetic Resonance Imaging , Male , Photography , Skull Neoplasms/diagnosis , Skull Neoplasms/etiology , Skull Neoplasms/pathology , Sphenoid Bone/pathology , Sphenoid Bone/surgery , von Hippel-Lindau Disease/complications
14.
J Neurosurg ; 92(4): 646-51, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10761655

ABSTRACT

OBJECT: The use of thrombolytic agents in the treatment of stroke has yielded surprisingly modest success, possibly because of reperfusion injury mediated by reactive oxygen species (ROS). Therefore, scavenging ROS may be of therapeutic value in the treatment of stroke. Nitroxides are low-weight superoxide dismutase mimics, which allows them to act as cell-permeable antioxidants. In this study the nitroxide 4-hydroxy-2,2,6,6,-tetramethylpiperidine-1-oxyl (Tempol) is investigated to determine its ability to reduce reperfusion injury. METHODS: Male Sprague-Dawley rats weighing between 280 g and 350 g underwent middle cerebral artery occlusion with an intraluminal suture for 60 minutes. Regional cerebral blood flow, blood pressure, cerebral temperature, and rectal temperature were monitored during the procedure. After reperfusion, the animals were randomized to groups receiving blinded intravenous administration of either Tempol (10 mg/kg; eight animals) or vehicle (eight animals) over the first 20 minutes of reperfusion (Study I). In a second study to determine dose dependency, animals were randomized to groups receiving Tempol (20 mg/kg; eight animals), low-dose Tempol (5 mg/kg; eight animals), or vehicle (eight animals; Study II). The rats were killed after 4 hours of reperfusion, and brain sections were stained with 2,3,5 triphenyltetrazolium chloride. Infarct volumes were measured using digital imaging. Animals receiving Tempol had significantly reduced infarct volumes at doses of 20 mg/kg and 10 mg/kg compared with controls (49.01+/-18.22% reduction [p = 0.003] and 47.47+/-34.57 [p = 0.02], respectively). No significant differences in the physiological variables measured were observed between groups. CONCLUSIONS: Tempol provides significant neuroprotection after reperfusion in a rat model of transient focal ischemia. These results support the importance of ROS in reperfusion injury and encourage further study of this molecule as a therapeutic agent following thrombolysis.


Subject(s)
Antioxidants/therapeutic use , Cyclic N-Oxides/therapeutic use , Ischemic Attack, Transient/complications , Neuroprotective Agents/therapeutic use , Reperfusion Injury/prevention & control , Animals , Antioxidants/administration & dosage , Blood Pressure/drug effects , Body Temperature/drug effects , Brain/drug effects , Cerebral Infarction/pathology , Cerebral Infarction/prevention & control , Cerebrovascular Circulation/drug effects , Coloring Agents , Cyclic N-Oxides/administration & dosage , Disease Models, Animal , Dose-Response Relationship, Drug , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/therapeutic use , Image Processing, Computer-Assisted , Injections, Intravenous , Ischemic Attack, Transient/pathology , Male , Pharmaceutical Vehicles , Random Allocation , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Reperfusion Injury/pathology , Single-Blind Method , Spin Labels , Superoxide Dismutase/therapeutic use , Tetrazolium Salts
15.
J Neurosurg ; 92(3): 413-8, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10701527

ABSTRACT

OBJECT: The authors present their neurosurgical experience with Carney complex. Carney complex, characterized by spotty skin pigmentation, cardiac myxomas, primary pigmented nodular adrenocortical disease, pituitary tumors, and nerve sheath tumors (NSTs), is a recently described, rare, autosomal-dominant familial syndrome that is relatively unknown to neurosurgeons. Neurosurgery is required to treat pituitary adenomas and a rare NST, the psammomatous melanotic schwannoma (PMS), in patients with Carney complex. Cushing's syndrome, a common component of the complex, is caused by primary pigmented nodular adrenocortical disease and is not secondary to an adrenocorticotropic hormone-secreting pituitary adenoma. METHODS: The authors reviewed 14 cases of Carney complex, five from the literature and nine from their own experience. Of the 14 pituitary adenomas recognized in association with Carney complex, 12 developed growth hormone (GH) hypersecretion (producing gigantism in two patients and acromegaly in 10), and results of immunohistochemical studies in one of the other two were positive for GH. The association of PMSs with Carney complex was established in 1990. Of the reported tumors, 28% were associated with spinal nerve sheaths. The spinal tumors occurred in adults (mean age 32 years, range 18-49 years) who presented with pain and radiculopathy. These NSTs may be malignant (10%) and, as with the cardiac myxomas, are associated with significant rates of morbidity and mortality. CONCLUSIONS: Because of the surgical comorbidity associated with cardiac myxoma and/or Cushing's syndrome, recognition of Carney complex has important implications for perisurgical patient management and family screening. Study of the genetics of Carney complex and of the biological abnormalities associated with the tumors may provide insight into the general pathobiological abnormalities associated with the tumors may provide insight into the general pathobiological features of pituitary adenomas and NSTs.


Subject(s)
Adenoma/surgery , Neoplastic Syndromes, Hereditary/surgery , Neurilemmoma/surgery , Peripheral Nervous System Neoplasms/surgery , Pituitary Neoplasms/surgery , Spinal Nerve Roots/surgery , Acromegaly/diagnosis , Acromegaly/genetics , Acromegaly/surgery , Adenoma/diagnosis , Adenoma/genetics , Adolescent , Adult , Chromosome Aberrations/genetics , Chromosome Disorders , Cushing Syndrome/diagnosis , Cushing Syndrome/genetics , Cushing Syndrome/surgery , Female , Genes, Dominant/genetics , Humans , Male , Middle Aged , Neoplastic Syndromes, Hereditary/diagnosis , Neoplastic Syndromes, Hereditary/genetics , Neurilemmoma/diagnosis , Neurilemmoma/genetics , Peripheral Nervous System Neoplasms/diagnosis , Peripheral Nervous System Neoplasms/genetics , Pituitary Neoplasms/diagnosis , Pituitary Neoplasms/genetics , Spinal Nerve Roots/pathology , Syndrome
16.
J Clin Psychol ; 56(2): 175-86, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10718601

ABSTRACT

The formation and maintenance of a positive working alliance is fundamental to the success of experiential therapy. Experiential therapists face a special challenge insofar as they must constantly consider whether to direct the therapeutic process more actively or remain more closely within the clients' own frame of reference. This requires that experiential therapists be acutely aware of the alliance with their clients on a moment-to-moment basis during the session. In this article ruptures to the alliance, comprising breakdowns In the agreement between clients and therapists as to the goals and tasks of therapy during the early and middle phases of treatment, are identified and explored. As ruptures are often covert processes, methods of detecting their occurrence during the session are presented. Finally, experiential techniques for forging, maintaining, and repairing the alliance between clients and therapists are discussed and illustrated.


Subject(s)
Cognitive Behavioral Therapy , Problem-Based Learning , Professional-Patient Relations , Psychoanalysis , Empathy , Humans , Models, Psychological
17.
Curr Treat Options Oncol ; 1(5): 375-86, 2000 Dec.
Article in English | MEDLINE | ID: mdl-12057145

ABSTRACT

Optimal therapy for pancreatic adenocarcinoma requires surgical removal with tumor-free margins. Superior outcomes have been reported for high-volume centers incorporating a multidisciplinary approach. Postoperative ("adjuvant") chemotherapy and radiation should be considered in patients with successfully resected primary tumors. Combined modality treatment with chemotherapy and radiation should be considered for locally advanced, unresectable tumors. Gemcitabine can provide symptom relief and a modest improvement in survival for patients with metastatic disease. Strict attention to relief of symptoms such as pain, depression, anorexia/cachexia, and jaundice is essential in all patients with pancreatic cancer. All patients with pancreatic cancer should be encouraged to enter clinical trials of new therapies, given that long-term survival for all stages remains poor.


Subject(s)
Adenocarcinoma/therapy , Pancreatic Neoplasms/therapy , Adenocarcinoma/pathology , Chemotherapy, Adjuvant , Clinical Trials as Topic , Combined Modality Therapy , Endoscopy , Humans , Pancreatectomy , Pancreatic Neoplasms/pathology , Postoperative Complications , Prognosis , Radiotherapy, Adjuvant , Survival Rate
19.
J Clin Endocrinol Metab ; 84(8): 2912-23, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10443699

ABSTRACT

Negative sellar exploration (despite the results of endocrine evaluation indicating Cushing's disease), the high incidence of failure of total hypophysectomy, and remission of Cushing's syndrome after unsuccessful hypophysectomy and sellar irradiation suggest that the etiology of refractory Cushing's disease, in some patients, lies near the sella but not in the pituitary gland. We present 5 patients, out of 626 who received surgery for Cushing's disease, in whom an ACTH-secreting extrapituitary parasellar adenoma was identified: 2 after unsuccessful total hypophysectomy for the treatment of refractory Cushing's disease, 2 after unsuccessful hemihypophysectomy (the first, 2 yr before treatment at the NIH for Nelson's syndrome; and the second, with recurrent Cushing's disease 5 yr after negative transsphenoidal exploration), and 1 with a preoperative diagnosis of an intraclival microadenoma, which was cured by resection of the tumor. In all cases, an extrapituitary parasellar microadenoma was confirmed unequivocally as the cause of the disease, by negative pathology of the resected pituitary gland (patients 1, 2, 3, and 5), and/or the remission of the disease after selective resection of the extrasellar adenoma (patients 3, 4, and 5). Three of 5 patients had a partial empty sella. These patients support the thesis that ACTH-secreting tumors can arise exclusively from remnants of Rathke's pouch, rather than from the adenohypophysis (anterior lobe or pars tuberalis of the pituitary gland) and can be a cause of Cushing's disease. In the sixth presented case, an extrapituitary tumor was suspected at surgery after negative pituitary exploration, but serial sections of the hemihypophysectomy specimen revealed a microscopic focus of tumor at the margin of the resected gland. This case demonstrates the importance of negative pituitary histology to establish the presence of an extrapituitary parasellar tumor as an exclusive source of ACTH, and it supports the value of clinical outcome to establish the diagnosis with selective adenomectomy of an extrapituitary parasellar tumor. In patients with negative pituitary magnetic resonance imaging, especially in the presence of a partial empty sella, the diagnostic and surgical approach in Cushing's disease should consider the identification and resection of extrapituitary parasellar adenoma, which can avoid total hypophysectomy, as was possible in 3 of our 5 patients.


Subject(s)
Adenoma/metabolism , Adrenocorticotropic Hormone/metabolism , Cushing Syndrome/etiology , Sella Turcica , Adenoma/diagnosis , Adenoma/pathology , Adrenocorticotropic Hormone/blood , Adult , Female , Humans , Male , Middle Aged
20.
Surgery ; 126(2): 358-63, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10455906

ABSTRACT

BACKGROUND: The timing and length of administration of angiogenesis inhibitor TNP-470 was altered to evaluate the effect on disease progression in a rat model of colorectal hepatic metastases. METHODS: Pair-fed BD-IX rats, injected intrasplenically with rat colon adenocarcinoma K12/TRb cells at day 0, were randomized to receive subcutaneous injections of either placebo or 15 mg/kg TNP-470 on alternate days: for 2 weeks beginning 24 hours after tumor inoculation ("Early"), for 4 weeks beginning 24 hours after tumor inoculation ("Prolonged"), or for 2 weeks beginning at day 15 after macroscopic tumor nodules were confirmed ("Delayed"). Response to treatment was evaluated by counting tumor nodules on the surface of the liver at laparotomy on day 14 and 28 after tumor inoculation. The animals were followed for survival and cause of death. RESULTS: Maximal suppression of hepatic metastases at day 28 required 4-week rather than 2-week TNP-470 administration. Prolonged TNP-470 administration resulted in significantly fewer hepatic metastases at day 28 compared to control (P < .05). Early and prolonged TNP-470 improved survival (Wilcoxon test, P < .05) compared with delayed TNP-470 and placebo. Delayed TNP-470 administration did not increase survival or significantly diminish the number of metastases at day 28 compared with placebo. CONCLUSIONS: These data suggest that prolonged adjuvant antiangiogenic therapy may suppress colorectal hepatic micrometastases.


Subject(s)
Antibiotics, Antineoplastic/therapeutic use , Colorectal Neoplasms/drug therapy , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/secondary , Neovascularization, Pathologic/prevention & control , Sesquiterpenes/therapeutic use , Animals , Colorectal Neoplasms/pathology , Cyclohexanes , Male , O-(Chloroacetylcarbamoyl)fumagillol , Rats , Sesquiterpenes/toxicity , Time Factors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...